In addition, by analysing other known clinical prognostic factors for high-grade glioma, we found that besides the miRNA signature identified (P = 7.36e-6), IDH1 mutation status was also associated with the survival of high-grade glioma patients in univariate analysis (P = 0.026). The gene discussed is IDH1; the disease is central nervous system cancer.